Nyxoah (NASDAQ:NYXH) Trading Up 0.6% – Should You Buy?

Nyxoah S.A. (NASDAQ:NYXH) was up 0.6% during trading on Thursday . The stock traded as high as $10.71 and last traded at $10.57. Approximately 35,985 shares traded hands during trading, a decline of 25% from the average daily volume of 48,234 shares. The stock had previously closed at $10.51.

Analyst Ratings Changes

Several research analysts have recently commented on NYXH shares. HC Wainwright reissued a “buy” rating and set a $17.00 price objective on shares of Nyxoah in a report on Friday, December 13th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $16.00 target price on shares of Nyxoah in a research note on Tuesday, November 5th. Five analysts have rated the stock with a buy rating, According to MarketBeat.com, Nyxoah presently has an average rating of “Buy” and an average target price of $17.00.

Nyxoah Stock Performance

The firm has a market cap of $358.65 million, a PE ratio of -5.63 and a beta of 1.41. The company has a 50 day simple moving average of $9.46 and a 200-day simple moving average of $8.91. The company has a debt-to-equity ratio of 0.21, a current ratio of 5.28 and a quick ratio of 4.95.

Institutional Trading of Nyxoah

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Geode Capital Management LLC lifted its position in Nyxoah by 19.4% in the fourth quarter. Geode Capital Management LLC now owns 17,100 shares of the company’s stock valued at $137,000 after purchasing an additional 2,774 shares during the last quarter. Walleye Capital LLC lifted its position in Nyxoah by 23.9% in the fourth quarter. Walleye Capital LLC now owns 14,831 shares of the company’s stock valued at $119,000 after purchasing an additional 2,862 shares during the last quarter. Kovack Advisors Inc. lifted its position in Nyxoah by 100.0% in the fourth quarter. Kovack Advisors Inc. now owns 20,000 shares of the company’s stock valued at $160,000 after purchasing an additional 10,000 shares during the last quarter. LPL Financial LLC bought a new stake in Nyxoah in the fourth quarter valued at approximately $102,000. Finally, Renaissance Technologies LLC bought a new stake in Nyxoah in the fourth quarter valued at approximately $187,000.

About Nyxoah

Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea.